Early agr Activation is a Key Pathogenic Signature in Persistent MRSA Bacteremia
Early agr Activation is a Key Pathogenic Signature in Persistent MRSA Bacteremia
批准号:
8224120
负责人:
YAN Q. XIONG
金额:
$18.3万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-02-01 至 2014-01-31
关键词:
AddressAdhesivesAntibioticsBacteremiaBiological MarkersCathetersCharacteristicsClinicalClinical TreatmentClinical TrialsCollectionCommunitiesComplexDaptomycinDataDevelopmentDiagnosticEndocarditisExhibitsFailureFoundationsGenerationsGenesGenetic TranscriptionGoalsHospitalsHumanIn VitroInfectionInfective endocarditisIntegration Host FactorsKnowledgeLifeMedicalModelingMolecularMorbidity - disease rateNorthern BlottingNosocomial InfectionsOryctolagus cuniculusOutcomePathogenesisPatientsPilot ProjectsProteinsRNAIIIRegulator GenesResearchResistanceReverse Transcriptase Polymerase Chain ReactionSelf-Sustained Sequence ReplicationSepsisSkinSolidStaphylococcus aureusStructureSurfaceSystemTestingTherapeuticVancomycinVirulenceVirulence Factorsantimicrobialclinical Diagnosisdesignearly onsetexperiencehigh riskin vivoinnovationmethicillin resistant Staphylococcus aureusmortalitynovelpathogenquorum sensingresearch studyresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Staphylococcus aureus is a predominant cause of community-acquired and nosocomial infections. In addition, it is the most common cause of skin and skin structure infections, and endocarditis, and is the second most common cause of bacteremia. Despite the use of new generation antibiotics, morbidity and mortality associated with S. aureus infections remain unacceptably high. Persistent MRSA bacteremia (PB) represents an important subset of S. aureus infections, and correlates with particularly severe outcomes. Therefore, PB presents a significant therapeutic challenge to the medical community. Understanding the relevant molecular mechanisms of PB is essential to optimize therapy against life-threatening S. aureus infections. Our preliminary data indicate that PB clinical outcomes significantly correlated with differences in key pathogenic characteristics as compared with resolving MRSA bacteremia (RB). These preliminary data provide a solid foundation to investigate our central hypotheses: early agr activation is an important pathogenic signature in persistent MRSA bacteremia. To test our hypotheses, we will achieve the following integrated Specfic Aims: 1) Define agr RNAIII transcription, functionality and locus sequence profiles in vitro in an expanded collection of well- characterized PB vs. RB strains; and 2) Define agr transcription and functionality in vivo using the experiment IE model, and evaluate the impact of these agr profiles on innate MRSA virulence and antimicrobial efficacy outcomes in the model. Northern blot analyses, gene sequence, nucleic acid sequence-based amplification (NASBA) and quantitative RT-PCR will be employed in this project. These studies will significantly advance our understanding the pathogenesis of MRSA infections. Our long-term goal is to identify unique PB signatures for development of rapid diagnostic means and novel antimicrobial strategies against MRSA infections, such as PB.
PUBLIC HEALTH RELEVANCE: Staphylococcus aureus is a predominant cause of community-acquired and nosocomial infections. Persistent MRSA bacteremia (PB) represents an important subset of S. aureus infections, and correlates with particularly severe outcomes. This study will significantly advance our understanding the pathogenesis of MRSA (i.e., early agr activation correlates of PB) and may provide new strategies to clinical diagnosis and treatment of S. aureus infections.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of purine biosynthesis and stringent response in persistent MRSA endovascular infections
-
批准号:10543433
-
项目类别:
-
资助金额:$45.08万
-
财政年份:2019
-
负责人:YAN Q. XIONG
-
依托单位:
Bicarbonate-Mediated Enhancement of Beta-Lactam-MRSA Killing: Mechanisms and Clinical Translatability
-
批准号:10626037
-
项目类别:
-
资助金额:$32.81万
-
财政年份:2019
-
负责人:YAN Q. XIONG
-
依托单位:
The role of purine biosynthesis and stringent response in persistent MRSA endovascular infections
-
批准号:10307524
-
项目类别:
-
资助金额:$45.08万
-
财政年份:2019
-
负责人:YAN Q. XIONG
-
依托单位:
Early agr Activation is a Key Pathogenic Signature in Persistent MRSA Bacteremia
-
批准号:8416324
-
项目类别:
-
资助金额:$20.66万
-
财政年份:2012
-
负责人:YAN Q. XIONG
-
依托单位:
海外基金